Still, the frequency of pathogenic MYD88 variants in our cohort of primary OA-DLBCL-NOS is slightly higher compared to DLBCL-NOS located in the lymph nodes (17–20%) [15,25]. Here, MYD88 is linked to diffuse large B-cell lymphoma.